1-7 of 7
Cesar Moran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer

Tina Cascone, Boris Sepesi, Heather Y. Lin, Neda Kalhor, Edwin R. Parra, Mei Jiang, Myrna C.B. Godoy, Jianjun Zhang, Frank V. Fossella, Anne S. Tsao, Vincent K. Lam, Charles Lu, Frank E. Mott, George R. Simon, Mara B. Antonoff, Reza J. Mehran, David C. Rice, Carmen Behrens, Annikka Weissferdt, Cesar Moran, Ara A. Vaporciyan, J. Jack Lee, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, William N. William, Jr., John V. Heymach
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (14): 3525–3536.
https://doi.org/10.1158/1078-0432.CCR-19-4180
Published: 15 July 2020
View articletitled, A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer
Open the PDF for A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer

Yang Xie, Wei Lu, Shidan Wang, Ximing Tang, Hao Tang, Yunyun Zhou, Cesar Moran, Carmen Behrens, Jack A. Roth, Qinghua Zhou, David H. Johnson, Stephen G. Swisher, John V. Heymach, Vassiliki A. Papadimitrakopoulou, Guanghua Xiao, John D. Minna, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 150–157.
https://doi.org/10.1158/1078-0432.CCR-17-2543
Published: 03 January 2019
View articletitled, Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Open the PDF for Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Edwin R. Parra, Carmen Behrens, Jaime Rodriguez-Canales, Heather Lin, Barbara Mino, Jorge Blando, Jianjun Zhang, Don L. Gibbons, John V. Heymach, Boris Sepesi, Stephen G. Swisher, Annikka Weissferdt, Neda Kalhor, Julie Izzo, Humam Kadara, Cesar Moran, Jack J. Lee, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (24): 6278–6289.
https://doi.org/10.1158/1078-0432.CCR-15-2443
Published: 15 December 2016
View articletitled, Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients
Open the PDF for Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients in another window
Includes: Supplementary data
Journal Articles

Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients

Yang Xie, Guanghua Xiao, Kevin R. Coombes, Carmen Behrens, Luisa M. Solis, Gabriela Raso, Luc Girard, Heidi S. Erickson, Jack Roth, John V. Heymach, Cesar Moran, Kathy Danenberg, John D. Minna, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5705–5714.
https://doi.org/10.1158/1078-0432.CCR-11-0196
Published: 01 September 2011
View articletitled, Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients
Open the PDF for Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Ximing Tang, Humam Kadara, Carmen Behrens, Diane D Liu, Yun Xiao, David Rice, Adi F. Gazdar, Junya Fujimoto, Cesar Moran, Marileila Varella-Garcia, J Jack Lee, Waun Ki Hong, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2434–2443.
https://doi.org/10.1158/1078-0432.CCR-10-1412
Published: 14 April 2011
View articletitled, Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis
Open the PDF for Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis in another window
Includes: Supplementary data
Journal Articles

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

Maria G. Raso, Carmen Behrens, Matthew H. Herynk, Suyu Liu, Ludmila Prudkin, Natalie C. Ozburn, Denise M. Woods, Ximing Tang, Reza J. Mehran, Cesar Moran, J. Jack Lee, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5359–5368.
https://doi.org/10.1158/1078-0432.CCR-09-0033
Published: 31 August 2009
View articletitled, Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation
Open the PDF for Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation in another window
Includes: Supplementary data
Journal Articles

Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer

Ludmila Prudkin, Carmen Behrens, Diane D. Liu, Xian Zhou, Natalie C. Ozburn, B. Nebiyou Bekele, John D. Minna, Cesar Moran, Jack A. Roth, Lin Ji, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 41–47.
https://doi.org/10.1158/1078-0432.CCR-07-1252
Published: 02 January 2008
View articletitled, Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer
Open the PDF for Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer in another window
Includes: Supplementary data